Bright Health Group Inc
NYSE:NEUE
Bright Health Group Inc
NYSE:NEUE
Price:
6.753
USD
Market Cap:
$60.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Bright Health Group Inc
NYSE:NEUE
|
US |
|
Ennis Inc
NYSE:EBF
|
US |
|
Telesis Bio Inc
NASDAQ:TBIO
|
US |
|
Zenith Minerals Ltd
ASX:ZNC
|
AU |
|
Pacific Health Care Organization Inc
OTC:PFHO
|
US |
|
Vetoquinol SA
PAR:VETO
|
FR |
|
C
|
CirChem AB
STO:CIRCHE
|
SE |
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
UK |
|
Pagegroup PLC
LSE:PAGE
|
UK |
|
Nanjing Gaoke Co Ltd
SSE:600064
|
CN |
|
I
|
Innovators Facade Systems Ltd
BSE:541353
|
IN |
|
C
|
CSSC Science & Technology Co Ltd
SSE:600072
|
CN |
|
City Pub Group PLC
LSE:CPC
|
UK |
|
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
|
IL |
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
CN |
|
Cardig Aero Services Tbk PT
IDX:CASS
|
ID |
|
A
|
Arcellx Inc
NASDAQ:ACLX
|
US |
|
A
|
Aion Therapeutic Inc
CNSX:AION
|
CA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NEUE's stock price target?
Not Available
NEUE doesn't have any price targets made by Wall Street professionals.
What is Bright Health Group Inc's Revenue forecast?
Projected CAGR
19%
19%
For the last 5 years the
compound annual growth rate for
Bright Health Group Inc's revenue is
27%.
The projected
CAGR
for the next 2 years is
19%.
